SearchDictionaryMobileLogin

D Zillikens Selected Research

Bullous Pemphigoid (Pemphigoid)

09/2005Successful adjuvant treatment of severe bullous pemphigoid by tryptophan immunoadsorption.
03/2004Elevated expression and release of tissue-type, but not urokinase-type, plasminogen activator after binding of autoantibodies to bullous pemphigoid antigen 180 in cultured human keratinocytes.
12/2001Cicatricial pemphigoid with circulating autoantibodies to beta4 integrin, bullous pemphigoid 180 and bullous pemphigoid 230.
11/2001Pemphigoid nodularis associated with autoantibodies to the NC16A domain of BP180 and a hyperproliferative integrin profile.
04/2001The IL-8 release from cultured human keratinocytes, mediated by antibodies to bullous pemphigoid autoantigen 180, is inhibited by dapsone.
11/2000Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes.
11/2000Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
11/2000Autoantibodies in anti-p200 pemphigoid stain skin lacking laminin 5 and type VII collagen.
04/2000Bullous pemphigoid of childhood: autoantibodies target the same epitopes within the NC16A domain of BP180 as autoantibodies in bullous pemphigoid of adulthood.
04/2000IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity.
02/2000Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid.

Articles by Research Topic

Disease

11Bullous Pemphigoid (Pemphigoid)
09/2005 - 02/2000
9Pemphigus (Pemphigus Vulgaris)
02/2008 - 11/2000
3Skin Diseases
12/2001 - 02/2000
2Benign Mucous Membrane Pemphigoid (Cicatricial Pemphigoid)
12/2001 - 11/2001
1Ectodermal Dysplasia (Aplasia Cutis Congenita)
10/2008
1Conjunctivitis
10/2008
1Dissociative Disorders (Fugue)
11/2006
1Pemphigoid Gestationis (Herpes Gestationis)
08/2003
1Lichen Planus (Lichen Ruber Planus)
03/2003
1Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa)
09/2002
1Blister (Bulla)
01/2001
1Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis)
11/2000
1Dermatitis Herpetiformis (Disease, Duhring's)
06/2000
1Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara)
02/2000

Drug/Important Bio-Agent (IBA)

11AutoantibodiesIBA
10/2008 - 02/2000
6Immunoglobulin G (IgG)IBA
11/2006 - 04/2000
6Immunoglobulin A (IgA)IBA
01/2005 - 05/2000
3Staphylococcal Protein A (A, Protein)IBA
02/2008 - 06/2003
3rituximab (Mabthera)FDA Link
02/2008 - 10/2003
3EpitopesIBA
08/2003 - 04/2000
3AntibodiesIBA
04/2001 - 06/2000
2DesmogleinsIBA
11/2006 - 01/2001
2Collagen Type VIIIBA
09/2002 - 11/2000
2Immunoglobulin E (IgE)IBA
06/2001 - 04/2000
2Interleukin-8 (Interleukin 8)IBA
04/2001 - 11/2000
1Intravenous Immunoglobulins (IVIG)FDA Link
02/2008
1Desmoglein 1IBA
11/2006
1Tryptophan (L-Tryptophan)FDA Link
09/2005
1AntigensIBA
03/2004
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
03/2004
1AcitretinFDA Link
03/2003
1Adrenal Cortex Hormones (Corticosteroids)IBA
03/2003
1AutoantigensIBA
12/2001
1Integrin beta4IBA
12/2001
1Desmoglein 3IBA
06/2001
1DapsoneFDA Link
04/2001
1Interleukin-6 (Interleukin 6)IBA
11/2000
1kalininIBA
11/2000
1Isotretinoin (Accutane)FDA LinkGeneric
11/2000
1Immunoglobulins (Immunoglobulin)IBA
04/2000
1collagen type XVII (collagen XVII)IBA
02/2000
1PlectinIBA
02/2000